Best Peptides for Inflammation
Anti-inflammatory peptides researched for reducing chronic inflammation, autoimmune support, and inflammatory pain.
Understanding Inflammation Peptides
Chronic inflammation drives many modern diseases. Anti-inflammatory peptides work through targeted mechanisms rather than the broad suppression of NSAIDs or corticosteroids. BPC-157 modulates nitric oxide and inflammatory pathways. KPV is a potent anti-inflammatory tripeptide derived from alpha-MSH that targets NF-kB signaling in the gut and systemically. LL-37 has dual antimicrobial and immunomodulatory effects. These peptides represent a precision approach to managing inflammation.
Key Considerations
- KPV specifically targets NF-kB, a master regulator of inflammation
- BPC-157 has broad anti-inflammatory effects across multiple tissue types
- Chronic inflammation has many root causes that should be investigated
- Anti-inflammatory peptides may complement but shouldn't replace medical treatment
- Diet, sleep, and stress management are foundational for inflammation control
Research Peptides (14)
These peptides are being researched but are not FDA approved. They should only be considered for research purposes or under medical supervision.
LL-37
Clinical TrialsA naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.
KPV
PreclinicalA tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH). Known for potent anti-inflammatory effects, particularly in the gut.
TB-500
PreclinicalA synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.
GHK-Cu
Clinical TrialsA naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Widely used in skincare for its wound healing and anti-aging properties.
Semax
Clinical TrialsA synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Approved in Russia for stroke and cognitive enhancement. Known for nootropic and neuroprotective effects.
Humanin
PreclinicalA mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity. Being studied for aging and metabolic benefits.
Thymosin Alpha-1
Clinical TrialsA naturally occurring thymic peptide that enhances immune function. Approved in over 35 countries for hepatitis B/C and as an immune adjuvant.
P21
PreclinicalA synthetic peptide mimetic of CNTF (ciliary neurotrophic factor) designed for neurodegenerative disease. Promotes neurogenesis and reduces neuroinflammation.
Matrixyl 3000
ResearchAn advanced version of Matrixyl combining two peptides for enhanced anti-aging effects. Targets both collagen production and inflammation.
VIP
Clinical TrialsA naturally occurring peptide with immunomodulatory and anti-inflammatory effects. Being studied for ARDS, pulmonary hypertension, and autoimmune conditions.
Thymosin Beta-4
Clinical TrialsThe full 43-amino acid protein that TB-500 is derived from. Naturally occurring in most human tissues, TB-4 has a shorter half-life (~2 hours) compared to its synthetic fragment TB-500 (~2-4 days). Often mislabeled as 'TB-500' by vendors in premixed products.
ARA-290
Clinical TrialsAn 11-amino acid peptide derived from erythropoietin (EPO) that activates the innate repair receptor. Unlike EPO, it has no erythropoietic activity but provides cytoprotective, anti-inflammatory, and tissue-protective effects.
KLOW Blend
PreclinicalAn advanced multi-peptide blend combining BPC-157 (10mg), TB-500 (10mg), GHK-Cu (50mg), and KPV (10mg) totaling 80mg per vial. Evolution of the Glow stack with added KPV for enhanced anti-inflammatory and gut health benefits.
BPC-157
PreclinicalA synthetic peptide derived from a protein found in human gastric juice. Known for its remarkable tissue healing properties across multiple body systems. FDA classified as Category 2 in 2023, restricting compounding.
Frequently Asked Questions
What peptides reduce inflammation?
KPV is one of the most targeted anti-inflammatory peptides, blocking NF-kB signaling. BPC-157 has broad anti-inflammatory effects especially in the GI tract and musculoskeletal system. LL-37 modulates immune responses. Thymosin Alpha-1 regulates immune balance.
How does KPV fight inflammation?
KPV (Lys-Pro-Val) is a tripeptide derived from alpha-MSH that inhibits NF-kB, the master switch of inflammatory gene expression. It has shown particular effectiveness in gut inflammation and has been researched for inflammatory bowel disease.
Are anti-inflammatory peptides safer than NSAIDs?
Peptides like KPV and BPC-157 appear to have fewer side effects than chronic NSAID use in preclinical studies — no GI bleeding or kidney concerns. However, they lack the extensive human safety data that NSAIDs have from decades of use.
Explore Other Goals
Compare Peptides Side-by-Side
Use our comparison tool to evaluate multiple peptides at once.
Looking for a trusted vendor?
Pro members get access to verified vendors with quality standards & exclusive discount codes.
Get Weekly Peptide Research Updates
New peptides, studies, and FDA changes delivered to your inbox.